Business Context and Reporting Period
This Form 8-K Current Report was filed by Boston Scientific Corporation on February 5, 2026, covering an event dated February 2, 2026. The filing addresses corporate governance matters regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of a director's departure and does not contain financial performance data.
Material Changes
The material change disclosed is the announcement that Yoshiaki Fujimori will not stand for re-election at the 2026 Annual Meeting of Stockholders. Mr. Fujimori has served on the Board since July 2016 and currently chairs the Risk, Science and Technology Committee. He will continue to serve in his roles until the Annual Meeting. The filing explicitly states this decision is not the result of any disagreement with the Company.
Outlook and Management Commentary
The Board and Nominating and Governance Committee stated they regularly review the size and composition of the Board. They will continue to evaluate whether adding directors following Mr. Fujimori's departure is in the best interest of the Company. No financial guidance or risk factors related to operations were disclosed in this specific filing.
Key Facts for Investor Verification
- Yoshiaki Fujimori will not seek re-election at the 2026 Annual Meeting.
- Mr. Fujimori remains a director and committee chair until the Annual Meeting concludes.
- The departure is voluntary and not due to any disagreement with the Company.
- The Board is currently evaluating whether to appoint a replacement director.